Depurinating naphthalene-DNA adducts in mouse skin related to cancer initiation

Free Radical Biology and Medicine

Volumn 47, Issue 7, 2009, Pages 1075-1081

  Saeed, Muhammad ^a   Higginbotham, Sheila ^a   Gaikwad, Nilesh ^a   Chakravarti, Dhrubajyoti ^a   Rogan, Eleanor ^a   Cavalieri, Ercole ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

1,2 Naphthalene quinone ultimate carcinogenic metabolite; Depurinating naphthalene DNA adducts; Metabolic activation of naphthalene; Naphthalene; Stable naphthalene DNA adducts

Indexed keywords

1 NAPHTHOL; 1,2 DIHYDRODIOLNAPHTHALENE; 1,2 NAPHTHALENEDIOL; 1,2 NAPHTHOQUINONE; DEOXYRIBONUCLEOTIDE; NAPHTHALENE; PHOSPHORUS 32; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APURINIC SITE; ARTICLE; CANCER RISK; CARCINOGEN DNA INTERACTION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; LIQUID CHROMATOGRAPHY; METABOLIC ACTIVATION; MOLECULAR STABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN CARCINOGENESIS; TANDEM MASS SPECTROMETRY;

ANIMALS; DNA ADDUCTS; MICE; MICE, INBRED SENCAR; NAPHTHALENES; SKIN NEOPLASMS;

MUS; RATTUS;

EID: 69249210944     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.07.020     Document Type: Article

References (41)

1. IARC. IARC monographs on the evaluation of carcinogenic risks to humans: some traditional herbal medicines, some mycotoxins, naphthalene and styrene Vol. 82 (2002), France, Lyon 367-435
2. Stanley J.S. Broad scan analysis of the FY82 national human adipose tissue survey specimens, executive summary (EPA-560/5-86-035), Volume 1 (1986), Environmental Protection Agency, office of toxic substances, Washington, DC
3. Pellizzari E.D., Hartwell T.D., Harris III B.S.H., Waddell R.D., Whitaker D.A., and Erickson M.D. Purgeable organic compounds in mother's milk. Bull. Environ. Contam. Toxicol. 28 (1982) 322-328
4. Environmental Protection Agency. Clean air act amendments of 1990 conference report to accompany S. 1630 (Report No. 101-952) (1990), Office of Pollution Prevention and Toxics, Washington, DC
5. Buckpitt A., Boland B., Isbell M., Morin D., Shultz M., Baldwin R., Chan K., Karlsson A., Lin C., Taff A., West J., Fanucchi M., Van Winkle L., and Plopper C. Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity. Drug. Metab. Rev. 34 (2002) 791-820
6. National Toxicology Program (NTP). Toxicology and carcinogenesis studies of naphthalene (CAS No. 91-20-3) in B6C3F1 mice (inhalation studies). Technical Report Series No. 410, NIH Publication No. 92-3141; Research Triangle Park, NC: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health; 1992.
7. Abdo K.M., Eustis S.L., McDonald M., Joiken M.P., Adkins B., and Haseman J.K. Naphthalene: a respiratory tract toxicant and carcinogen for mice. Inhal. Toxicol. 4 (1992) 393-409
8. Abdo K.M., Grumbein S., Chou B.J., and Herbert R. Toxicity and carcinogenicity study in F344 rats following 2 years of whole-body exposure to naphthalene vapors. Inhal. Toxicol. 13 (2001) 931-950
9. National Toxicology Program (NTP). Toxicology and carcinogenesis studies of naphthalene (CAS No. 91-20-3) in F344/N rats (inhalation studies). CNTP Technical Report Series No. 500; NIH publication No. 01-4434, Research Triangle Park, NC. 2000
10. North D.W., Abdo K.M., Benson J.M., Dahl A.R., Morris J.B., Renne R., and Witschi H. A review of whole animal bioassays of the carcinogenic potential of naphthalene. Regul. Toxicol. Pharmacol. 51 (2008) 6-14
11. Buckpitt A.R., Castagnoli N., Nelson S.D., Jones A.D., and Bahnson L.S. Stereoselectivity of naphthalene epoxidation by mouse, rat and hamster pulmonary, hepatic and renal microsomal enzymes. Drug Metab. Dispos. 15 (1987) 491-498
12. Jerina D.M., Daly J.W., Witkop B., Zaltzman-Nirenberg Z., and Udenfriend S. 1,2-Naphthalene oxide as an intermediate in the microsomal hydroxylation of naphthalene. Biochemistry 9 (1970) 147-156
13. Van Bladeren P.J., Vyas K.P., Sayer J.M., Ryan D.E., Thomas P.E., Levin W., and Jerina D.M. Stereoselectivity of cytochrome P-450c in the formation of naphthalene and anthracene 1,2-oxides. J. Biol. Chem. 259 (1984) 8966-8973
14. Kanekal S., Plopper C., Morin D., and Buckpitt A. Metabolism and cytotoxicity of naphthalene oxide in the isolated perfused mouse lung. J. Pharmacol. Exp. Ther. 256 (1991) 391-401
15. Buckpitt A.R., and Bahnson L.S. Naphthalene metabolism by human lung microsomal enzymes. Toxicology 41 (1986) 333-341
16. Tingle M.D., Pirmohamed M., Templeton E., Wilson A.S., Madden S., Kitteringham N.R., and Park B.K. An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes. Biochem. Pharmacol. 46 (1993) 1529-1538
17. Smithgall T.E., Harvey R.G., and Penning T.M. Spectroscopic identification of ortho-quinones as the products of polycyclic aromatic trans-dihydrodiol oxidation catalyzed by dihydrodiol dehydrogenase. J. Biol. Chem. 263 (1988) 1814-1820
18. Turkall R.M., Skowronski G.A., Kadry A.M., and Abdel-Rahman M.S. A comparative study of the kinetics and bioavailability of pure and soil-absorbed naphthalene in dermally exposed male rats. Arch. Environ. Toxicol. 26 (1994) 504-509
19. Bakke J., Struble C., Gustafsson J.-Å., and Gustafsson B. Catabolism of premercapturic acid pathway metabolites of naphthalene to naphthols and methylthio-containing metabolites in rats. Biochemistry 82 (1985) 668-671
20. d'Arcy Doherty M., Makowski R., Gibson G.G., and Cohen G.M. Cytochrome P-450 dependent metabolic activation of 1-naphthol to naphthoquinones and covalent binding species. Biochem. Pharmacol. 34 (1985) 2261-2267
21. Flueraru M., Chichirau A., Chepelev L.L., Willmore W.G., Durst T., Charron M., Barclay L.R., and Wright J.S. Cytotoxicity and cytoprotective activity in naphthalenediols depends on their tendency to form naphthoquinones. Free Radic. Biol. Med. 39 (2005) 1368-1377
22. Saeed M., Higginbotham S., Rogan E., and Cavalieri E. Formation of depurinating N3adenine and N7guanine adducts after reaction of 1,2-naphthoquinone or enzyme-activated 1,2-dihydroxynaphthalene with DNA. Implications for the mechanism of tumor initiation by naphthalene. Chem.-Biol. Interact. 165 (2007) 175-188
23. Platt K.L., and Oesch F. Efficient synthesis of non-K-region trans-dihydro diols of polycyclic aromatic hydrocarbons from o-quinones and catechols. J. Org. Chem. 48 (1983) 265-268
24. 32P-Postlabeling analysis of benzo[a]pyrene-DNA adducts formed in vitro and in vivo. Chem. Res. Toxicol. 2 (1989) 312-315
25. 32P-Postlabeling/polyacrylamide gel electrophoresis analysis: application to the detection of DNA adducts. Chem. Res. Toxicol. 15 (2002) 305-311
26. Devanesan P.D., RamaKrishna N.V.S., Padmavathi N.S., Higginbotham S., Rogan E.G., Cavalieri E.L., Marsch G.A., Jankowiak R., and Small J.G. Identification and quantitation of 7,12-dimethylbenz[a]anthracene-DNA adducts formed in mouse skin. Chem. Res. Toxicol. 6 (1993) 364-371
27. Wu R., Waidyanatha S., Henderson A.P., Serdar B., Zheng Y., and Rappaport S.M. Determination of dihydroxynaphthalenes in human urine by gas chromatography-mass spectrometry. J. Chromatogr. B 826 (2005) 206-213
28. Cavalieri E., and Rogan E. Mechanisms of tumor initiation by polycyclic aromatic hydrocarbons in mammals. In: Neilson A.H. (Ed). The handbook of environmental chemistry. PAHs and related compounds vol. 3J (1998), Springer-Verlag, Heidelberg 81-117
29. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S., Johansson S.L., Patil K.D., Gross M.L., Gooden J.K., Ramanathan R., Cerny R.L., and Rogan E.G. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA 94 (1997) 10937-10942
30. Li K.M., Todorovic R., Devanesan P., Higginbotham S., Kofeler H., Ramanathan R., Gross M.L., Rogan E.G., and Cavalieri E.L. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 25 (2004) 289-297
31. Zahid M., Kohli E., Saeed M., Rogan E., and Cavalieri E. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity. Chem. Res. Toxicol. 19 (2006) 164-172
32. Saeed M., Zahid M., Gunselman S.J., Rogan E., and Cavalieri E. Slow loss of deoxyribose from the N7deoxyguanosine adducts of estradiol-3,4-quinone and hexestrol-3′,4′-quinone. Implications for mutagenic activity. Steroids 70 (2005) 29-35
33. Saeed M., Gunselman S.J., Higginbotham S., Rogan E., and Cavalieri E. Formation of the depurinating N3Adenine and N7Guanine adducts by reaction of DNA with hexestrol-3′,4′-quinone or enzyme activated 3′-hydroxyhexestrol. Implications for a unifying mechanism of tumor initiation by natural and synthetic estrogens. Steroids 70 (2005) 37-45
34. Saeed M., Rogan E., and Cavalieri E. Mechanism of metabolic activation and DNA adduct formation by the human carcinogen diethylstilbestrol: the defining link to natural estrogens. Int. J. Cancer 124 (2009) 1276-1284
35. Cavalieri E.L., Li K.-M., Balu N., Saeed M., Devanesan P., Higginbotham S., Zhao J., Gross M.L., and Rogan E. Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis 23 (2002) 1071-1077
36. Cavalieri E., and Rogan E. Catechol quinones of estrogen in the initiation of breast, prostate, and other human cancers. Ann. N. Y. Acad. Sci. 1089 (2006) 286-301
37. Chakravarti D., Mailander P., Li K.-M., Higginbotham S., Zhang H., Gross M.L., Cavalieri E., and Rogan E. Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene 20 (2001) 7945-7953
38. Mailander P.C., Meza J.L., Higginbotham S., and Chakravarti D. Induction of A.T to G.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats. J. Steroid Biochem. Mol. Biol. 101 (2006) 204-215
39. Zhao Z., Kosinska W., Khmelnitsky M., Cavalieri E.L., Rogan E.G., Chakravarti D., Sacks P., and Guttenplan J.B. Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB2 rat embryonic cells, and the mutational spectrum of 4-hydoxyestradiol. Chem. Res. Toxicol. 19 (2006) 475-479
40. Rogan E.G., Devanesan P.D., RamaKrishna N.V.S., Higginbotham S., Padmavathi N.S., Chapman K., Cavalieri E.L., Jeong H., Jankowiak R., and Small G.J. Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skin. Chem. Res. Toxicol. 6 (1993) 356-363
41. Chakravarti D., Mailander P.C., Cavalieri E.L., and Rogan E.G. Evidence that error-prone DNA repair converts dibenzo[a,l]pyrene-induced depurinating lesions into mutations: formation, clonal proliferation and regression of initiated cells carrying H-ras oncogene mutations in early preneoplasia. Mutat. Res. 456 (2000) 17-32